Greene Barry E
SEC insider (Form 3/4/5 filer). CIK 0001291963. Director at CITY THERAPEUTICS, INC. (CTY) and 3 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2026. Located in CAMBRIDGE, MA.
Companies Greene Barry E has filed insider reports for
- CITY THERAPEUTICS, INC. (CTY): Director
- Dyne Therapeutics, Inc. (DYN): Director
- Karyopharm Therapeutics Inc. (KPTI): Director
- Sage Therapeutics, Inc. (SAGE): Director, Officer, President and CEO
Greene Barry E
CIK: 0001291963
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Oct 15, 2026CTY
CITY THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
22.6K shares- - Jun 22, 2026DYN
Dyne Therapeutics, Inc.
AwardDirectStock option (right to buy)
57.5K shares- - May 21, 2026KPTI
Karyopharm Therapeutics Inc.
AwardDirect15.5K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
Tender OfferDirect46.9K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirect53.2K shares- - May 28, 2025KPTI
Karyopharm Therapeutics Inc.
AwardDirectNonstatutory Stock Option (right to buy)
4.6K shares- - Apr 10, 2025SAGE
Sage Therapeutics, Inc.
Tax PaymentDirect4.9K shares at avg. $6.91$34K - Apr 10, 2025SAGE
Sage Therapeutics, Inc.
AwardDirect20K shares- - Jan 16, 2025SAGE
Sage Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
174K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | CTY CITY THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 22,649 | - | - | Direct |
| Jun 22, 2026 | DYN Dyne Therapeutics, Inc. | Award Stock option (right to buy) | 57,463 | - | - | Direct |
| May 21, 2026 | KPTI Karyopharm Therapeutics Inc. | Award | 15,508 | - | $0 | Direct |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Tender Offer | 46,940 | - | - | Direct |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Disposition | 53,229 | - | - | Direct |
| May 28, 2025 | KPTI Karyopharm Therapeutics Inc. | Award Nonstatutory Stock Option (right to buy) | 4,600 | - | - | Direct |
| Apr 10, 2025 | SAGE Sage Therapeutics, Inc. | Tax Payment | 4,862 | $6.91 | $33,596 | Direct |
| Apr 10, 2025 | SAGE Sage Therapeutics, Inc. | Award | 19,964 | - | - | Direct |
| Jan 16, 2025 | SAGE Sage Therapeutics, Inc. | Award Stock Option (Right to Buy) | 174,000 | - | - | Direct |
1-9 of 9 transactions